ACOG joins Jay Monahan Center to develop new chapter on Female Cancers resource guide

NewsGuard 100/100 Score

The New York State Chapter of the American Congress of Obstetricians and Gynecologists, District II (ACOG) has partnered with the Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center to develop the fifth and final chapter to the Focus on Female Cancers resource guide.

This new chapter focuses on colorectal cancer, how to recognize risk factors and recommend the appropriate screening. An electronic version of the chapter can be found here.

Colorectal cancer (often referred to as colon cancer) is a slow-growing cancer that affects the cells in the colon and rectum and can spread to other parts of the body. It is the second-leading cause of death among men and women combined in the United States, and the third-leading cause of cancer death among women alone.

"Women's health care providers, especially ob-gyns, may be the only doctors some women see regularly, so they play a vital role in discussing colorectal cancer with patients," said Maureen Killackey, MD, FACOG, FACS, Co-Chair of the ACOG District II Colorectal Cancer Task Force. "This chapter includes information on risk assessment, evidence-based screening and surveillance guidelines, as well as office management strategies for increasing appropriate colorectal cancer screening."

"We are thrilled that ACOG is providing this valuable educational resource to underscore colorectal cancer screening as a major women's health imperative, along with breast and cervical cancer screening," said Mark Pochapin, MD, Director of The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Co-Chair of the ACOG District II Colorectal Cancer Task Force. "It is important for women to know that colorectal cancer affects both men and women, and that screening is done when they feel well, before symptoms develop."

In its early stages, colorectal cancer often causes no signs or symptoms. With screening and early detection, colorectal cancer is often preventable and highly curable. Colorectal cancer screening is recommended for all women (and men) age 50 and older. Individuals with certain risk factors-such as personal or family history of colorectal polyps or cancer; personal history of inflammatory bowel disease; or diagnosed or suspected hereditary colorectal cancer syndrome-should talk to their doctor about starting screening at a younger age.

The Focus on Female Cancers resource guide, packaged in a three ring binder form, has been distributed free of charge to ACOG doctors, New York State Cancer Services Program providers, and women's health care practitioners across New York State. Published chapters also include:
•Cervical Cancer
•Hereditary Breast and Ovarian Cancer
•Cancer Survivorship
•Ovarian Cancer

"We are very proud of this nationally recognized provider education guide," said Donna Montalto, MPP, Executive Director of ACOG District II. "It has played a major role in giving physicians, nurses, and patients important scientific information about many types of female cancers."

Source:

Jay Monahan Center for Gastrointestinal Health

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis